Back to top
more

Pediatrix Medical Group, Inc. (MD)

(Delayed Data from NYSE)

$21.38 USD

21.38
890,703

-0.36 (-1.66%)

Updated Apr 8, 2026 04:00 PM ET

After-Market: $21.39 +0.01 (0.05%) 7:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.93%
2Buy18.12%
3Hold10.10%
4Sell5.65%
5Strong Sell2.94%
S&P50011.36%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (141 out of 243)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Brokerage Reports

Research for MD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

2 items in cart

View Cart/Checkout

Pediatrix Medical Group, Inc. [MD]

Reports for Purchase

Showing records 301 - 320 ( 406 total )

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 301

02/01/2013

Company Report

Pages: 8

Solid organic trends plus high appetite for acquisitions to fuel additional growth

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 302

02/01/2013

Company Report

Pages: 7

Solid 4Q, 1Q Conservative, Outlook Remains Positive - Affirm Buy and Raise PT from $95 to $110

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 303

01/29/2013

Company Report

Pages: 9

Preliminary low weight birth data suggests inline trends

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 304

01/03/2013

Daily Note

Pages: 6

2013 Top Ideas

Provider: FELTL & COMPANY

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 305

12/21/2012

Company Report

Pages: 7

Raising estimates for anesthesia acquisition and Medicaid parity ruling

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 306

11/05/2012

Company Report

Pages: 8

3Q Beats By $0.05. 4Q Guidance Well Above Consensus. Reimbursement Parity Will Help In 2013, 2014. Anesthesia Acceleration Just Beginning. Expect Breakout Year In 2013. Affirm Buy Rating And $95 PT.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 307

11/05/2012

Company Report

Pages: 6

Q3/2012 - Another positive surprise

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 308

11/02/2012

Company Report

Pages: 7

Better than expected results; CMS finalizes Medicaid parity, estimates to increase

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 309

10/31/2012

Company Report

Pages: 9

Preliminary low weight birth data reflects solid 3Q12 trends

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 310

09/20/2012

Company Report

Pages: 8

Investor Meeting Highlights Anesthesia Opportunity. Acceleration Just Beginning. Expect Breakout .

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 311

09/20/2012

Company Report

Pages: 7

Analyst Day sets the stage for national anesthesia presence

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 312

08/03/2012

Company Report

Pages: 6

MD Q2/12 Surprise on upside, Acquisition activity picks up Maintain Buy and $80.00 price target

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 313

08/01/2012

Company Report

Pages: 8

MD Better than expected results inline with our propriety research; raising estimates

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 314

08/01/2012

Company Report

Pages: 8

MD: Solid 2Q. Anesthesia To Accelerate. Reimbursement To Increase. Affirm Buy And Raise PT To $95.

Provider: COLLIERS SECURITIES

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 315

07/26/2012

Company Report

Pages: 8

Preliminary birth weight data suggests improving Pediatrix trends

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 316

07/13/2012

Company Report

Pages: 8

ACA Should Result In Favorable Reimbursement. Also Expect Anesthesia Acceleration To Contribute To Faster Growth. Affirm Buy Rating And $80 PT.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 317

07/05/2012

Daily Note

Pages: 6

2H:2012 Top Ideas

Provider: FELTL & COMPANY

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 318

05/21/2012

Company Report

Pages: 6

MD: Q1/2012 results in line; Maintain Buy

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 319

05/07/2012

Company Report

Pages: 8

MD: 2Q To Be Soft. Expect Anesthesia Acceleration To Drive Growth.Affirm Buy Rating. Reducing PT From $100 To $80.

Provider: COLLIERS SECURITIES

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 320

05/04/2012

Company Report

Pages: 8

1Q12 results below expectations as margins get squeezed

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party